VEGF, BFGF \& ENDOSTATIN DO NOT PREDICT PROGNOSIS IN HEPATOCELLULAR CARSINOMA PATIENTS

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSykymbayev, A.
dc.contributor.authorEren, F.
dc.contributor.authorTiftikci, A.
dc.contributor.authorTuere, F.
dc.contributor.authorGuenduez, F.
dc.contributor.authorOzdogan, O.
dc.date.accessioned2025-10-16T15:39:22Z
dc.date.issued2010
dc.description.abstract45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, AUSTRIA, APR 14-18, 2010
dc.identifier.doi10.1016/S0168-8278(10)60597-1
dc.identifier.otherWOS:000277018001221
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9878
dc.publisherELSEVIER SCIENCE BV
dc.sourceJOURNAL OF HEPATOLOGY
dc.titleVEGF, BFGF \& ENDOSTATIN DO NOT PREDICT PROGNOSIS IN HEPATOCELLULAR CARSINOMA PATIENTS
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS